Yes, I agree, they are working on getting I's dotted and T's crossed regarding getting their BLA ready but what I don't agree on is that they submitted the BLA and/or getting fast tracked/rolling review type stuff. You would hear about it first. They wouldn't be hiding that.
And regarding new clinical trials, I agree, the sure fire way to find out about them is via the clinical trials database.
And in both cases, we would get a inkling of how things are going if they had quarterly meetings and/or Analyst CCs. Hopefully, they'll start doing that soon after TLD is out.
News 
Market Data 
Discover 
AI
